MANKIND PHARMA
Back to Income Statement
|
MANKIND PHARMA Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Adjusted EPS | ₹32.00 | ₹35.78 | ₹31.59 | ₹25.72 | ₹14.44 |
What is the latest Earnings Per Share (EPS) of MANKIND PHARMA ?
Year | Earnings Per Share (EPS) |
---|---|
Mar2023 | ₹32.00 |
Mar2022 | ₹35.78 |
Mar2021 | ₹31.59 |
Mar2020 | ₹25.72 |
Mar2019 | ₹14.44 |
How is Earnings Per Share (EPS) of MANKIND PHARMA Trending?
Years | Earnings Per Share (EPS) | % Change | |
---|---|---|---|
Mar2023 | ₹32.00 | -10.56 | |
Mar2022 | ₹35.78 | 13.26 | |
Mar2021 | ₹31.59 | 22.82 | |
Mar2020 | ₹25.72 | 78.12 | |
Mar2019 | ₹14.44 | - |
Compare Earnings Per Share (EPS) of peers of MANKIND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANKIND PHARMA | ₹84,684.8 Cr | 0.3% | -10.7% | 59.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹351,467.0 Cr | -4.9% | -2.6% | 54% | Stock Analytics | |
CIPLA | ₹119,470.0 Cr | -0.1% | 5% | 57.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹116,563.0 Cr | 8.1% | 9.1% | 25.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹105,690.0 Cr | -2.4% | 10.8% | 110% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,351.1 Cr | 1.4% | -4.8% | 30.2% | Stock Analytics |
MANKIND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANKIND PHARMA | 0.3% |
-10.7% |
59.9% |
SENSEX | 1.7% |
1.1% |
21.3% |
You may also like the below Video Courses